HSCT approach provides ‘excellent’ survival in FAMarch 2, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLMyelodysplastic Syndrome
EC approves emicizumab for hemophilia A with inhibitorsMarch 2, 2018ThrombosisPharmacyBleeding Disorders
Study confirms higher risk of infection with CB transplantMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends approval for GO in AMLMarch 1, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Company withdraws application for idelalisibMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
CHMP endorses drug delivery systemMarch 1, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyRelated Issues
CHMP backs bosutinib for newly diagnosed CMLFebruary 28, 2018Leukemia, Myelodysplasia, TransplantationPharmacyCML
Expanded UCB product can stand aloneFebruary 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAMLALLMyelodysplastic Syndrome
